Tuesday, June 9, 2020

Dwindling Prader-Willi Syndrome Drug Development Landscape And Hopeful Therapies

Although there are FDA approved therapies for the treatment of growth failure in children with PWS, say, Pfizer's (PFE) recombinant human growth hormone Genotropin (somatropin) and Sandoz/Novartis' Omnitrope, a biosimilar for Genotropin, there is no approved therapy yet to treat hyperphagia or excessive eating, the cardinal symptom of PWS.

from RTT - Biotech https://ift.tt/2XMfxbX
via IFTTT

No comments:

Post a Comment